Economic consequences of idiopathic pulmonary fibrosis in Denmark

When a patient is diagnosed with IPF, the net health costs increase from €2753 to €21 184 per year even without the cost of antifibrotic treatment. Inpatient treatment accounts for the main part of the expenses http://ow.ly/dSsn30jEx0p

Detalles Bibliográficos
Autores principales: Hilberg, Ole, Bendstrup, Elisabeth, Ibsen, Rikke, Løkke, Anders, Hyldgaard, Charlotte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2018
Materias:
Original Research Letters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5968194/
https://www.ncbi.nlm.nih.gov/pubmed/29850467
http://dx.doi.org/10.1183/23120541.00045-2017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5968194/
https://www.ncbi.nlm.nih.gov/pubmed/29850467
http://dx.doi.org/10.1183/23120541.00045-2017

Ejemplares similares